Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.
Cellares
4 followers
Tango Therapeutics
3 followers
Dyno Therapeutics
4 followers
Odyssey Therapeutics
3 followers
Gilead Sciences
169 followers
Regeneron
140 followers
Illumina
80 followers
Agilent Technologies
88 followers
Verily Life Sciences
47 followers
Alexion Pharmaceuticals
48 followers
GRAIL
30 followers
Explore companies